Long-Term Interferon-Alpha Treatment Suppresses Tumor Growth But Promotes Metastasis Capacity In Hepatocellular Carcinoma

Peng-Yuan Zhuang,Ju-Bo Zhang,Wei Zhang,Xiao-Dong Zhu,Ying Liang,Hua-Xiang Xu,Yu-Quan Xiong,Ling-Qun Kong,Lu Wang,Wei-Zhong Wu,Zhao-You Tang,Lun-Xiu Qin,Hui-Chuan Sun
DOI: https://doi.org/10.1007/s00432-010-0848-1
2010-01-01
Journal of Cancer Research and Clinical Oncology
Abstract:To elucidate the effect of IFN-alpha treatment on tumor growth and metastasis of hepatocellular carcinoma (HCC).IFN-alpha administration was conducted in nude mice using an orthotopic implantation model of human HCC, and the key molecular markers in the IFN-alpha treatment was detected by immunohistochemistry staining and PCR array.Up to 12 weeks of IFN-alpha treatment significantly suppressed tumor growth of HCC, but relatively increased the number of circulating tumor cells, which might be due to the enhanced tumor hypoxia as well as up-regulation of metastasis-related genes, such as HIF-1 alpha, c-met, u-PA, PDGF-A, and IL-8. However, IFN-alpha had no direct effect on migration and invasion of HCC cells.IFN-alpha has janus face of consistently suppressing HCC growth, however, promoting tumor metastasis capacity, which is of clinical indication for the scientific administration of IFN-alpha and the similar antiangiogenesis drugs for their dual effect on tumor growth and metastasis.
What problem does this paper attempt to address?